Vimarsana
Biggest News Aggregation in the World

Harmful Use News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harmful Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harmful Use Today - Breaking & Trending Today

Concerted efforts urgently needed to meet 203 - Vimarsana News

Concerted efforts urgently needed to meet 203

<p>Concerted international efforts are urgently needed to meet the targets set out in the 2030 Global Alcohol Action Plan (GAAP) and avert &ldquo;dire consequences&rdquo; for low and middle income countries, where alcohol markets are expanding, warn health scientists in the open access journal&nbsp;<em><strong>BMJ Global Health.</strong></em></p>

Liquor Amendment Bill under the spotlight - Vimarsana News

Liquor Amendment Bill under the spotlight

Social Development Minister Lindiwe Zulu has acknowledged the message of the 7th

Ferguson: We were far down the wicket with alcohol policy - Vimarsana News

Ferguson: We were far down the wicket with alcohol policy

Former Minister of Health Dr Fenton Ferguson has disclosed that the drafting of legislation for a policy on alcohol was being worked on, soon after the Tobacco Control Bill was placed before Parli...

Tackling the cause of fatal crashes - Jamaica Observer - Vimarsana News

Tackling the cause of fatal crashes - Jamaica Observer

The National Council on Drug Abuse (NCDA) believes that people involved in road crashes — fatal or otherwise — should be subjected to mandatory testing for substance abuse, and is pointing to an i...

Clairvoyant Therapeutics: First Patient Dosed in Clairvoyant's Phase 2 Clinical Trial Exploring Psilocybin as a Treatment for Alcohol Use Disorder - Vimarsana News

Clairvoyant Therapeutics: First Patient Dosed in Clairvoyant's Phase 2 Clinical Trial Exploring Psilocybin as a Treatment for Alcohol Use Disorder

VANCOUVER, BC / ACCESSWIRE / November 3, 2022 / Clairvoyant Therapeutics ("Clairvoyant"), a clinical stage biotech company focused on the development of psychedelic drug therapies for the treatment of